Poursuite du traitement d’une polymyositepar les immunoglobulines intraveineuses polyvalentesmalgré la survenue d’une anémie hémolytique sévère
Authors:
- R MortelecqueRMR Mortelecque
- M SinègreMSM Sinègre
- A MarceauAMA Marceau
- G DauriatGDG Dauriat
- F CourtoisFCF Courtois
- 1 April 2001
- journal article
- case report
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 8 (2) , 94-99
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- In vivoAdministration of Intravenous Immunoglobulin (IVIg) can Lead to Enhanced Erythrocyte SequestrationJournal of Autoimmunity, 1999
- Isoantibodies in Immunoglobulin for Intravenous Use May Cause Erythrocyte SequestrationVox Sanguinis, 1999
- Les immunoglobulines intraveineuses dans les polymyosites et les dermatomyositesLa Revue de Médecine Interne, 1999
- Immune complex-like moieties in immunoglobulin for intravenous use (IVIg) bind complement and enhance phagocytosis of human erythrocytesClinical and Experimental Immunology, 1998
- Hemolytic anemia associated with intravenous immunoglobulinMuscle & Nerve, 1997
- Hemolysis after high-dose intravenous Ig [letter]Blood, 1993
- Massive Intravascular Hemolysis Associated with Intravenous Immunoglobulin in Bone Marrow Transplant RecipientsJournal of Pediatric Hematology/Oncology, 1988
- Hemolytic anemia following intravenous gamma globulin administrationThe American Journal of Medicine, 1987
- Hemolysis following intravenous immune globulin therapyTransfusion, 1986
- Hemolysis due to High-Dose Intravenous Gammaglobulin Treatment for Patients with Idiopathic Thrombocytopenic PurpuraActa Haematologica, 1986